Estimation of the Antirelapse Efficacy of Tafenoquine, UsingPlasmodium vivaxGenotyping-Reference-Cited by-同舟云学术

Estimation of the Antirelapse Efficacy of Tafenoquine, UsingPlasmodium vivaxGenotyping

Published:2015-10-23 Issue:5 Volume:213 Page:794-799
ISSN:0022-1899
Container-title:Journal of Infectious Diseases
language:en
Short-container-title:J Infect Dis.

Author:

Beck Hans-Peter,Wampfler Rahel,Carter Nick,Koh Gavin,Osorio Lyda,Rueangweerayut Ronnatrai,Krudsood Srivcha,Lacerda Marcus V.,Llanos-Cuentas Alejandro,Duparc Stephan,Rubio Justin P.,Green Justin A.

Funder

GlaxoSmithKline, Medicines

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/213/5/794/7425743/jiv508.pdf

Reference14 articles.

1. The Global Public Health Significance of Plasmodium vivax

2. Killing the hypnozoite—drug discovery approaches to prevent relapse in Plasmodium vivax;Campo;Pathog Glob Health,2015

3. Evaluation ofPlasmodium vivaxGenotyping Markers for Molecular Monitoring in Clinical Trials

4. Multiplicity and Diversity of Plasmodium vivax Infections in a Highly Endemic Region in Papua New Guinea

5. Using Amplicon Deep Sequencing to Detect Genetic Signatures ofPlasmodium vivaxRelapse

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artemisinin-naphthoquine plus lower-dose primaquine to treat and prevent recurrence of Plasmodium vivax malaria: an open-label randomized and non-inferiority trial;Parasites & Vectors;2024-01-22

2. Artemisinin-naphthoquine plus lower-dose primaquine to treat and prevent recurrence of Plasmodium vivax malaria: an open-label randomized and non-inferiority trial;2023-07-18

3. Malaria Resilience in South America: Epidemiology, Vector Biology, and Immunology Insights from the Amazonian International Center of Excellence in Malaria Research Network in Peru and Brazil;The American Journal of Tropical Medicine and Hygiene;2022-10-11

4. Eficacia de la tafenoquina en la profilaxis y tratamiento de la malaria por Plasmodium vivax, revisión sistemática y metaanálisis;Biomédica;2022-06-01

5. Higher-Dose Primaquine to Prevent Relapse of Plasmodium vivax Malaria;New England Journal of Medicine;2022-03-31